Emily Pimblett
Fortune : 259 332 $ au 31/08/2026
Fortune : 259 332 $ au 31/08/2026
Emily Pimblett worked as Controller at Avvo, Inc. from 2017 to 2019.
Ms. Pimblett worked as Controller at DomainTools LLC from 2019 to 2021.
Ms. Pimblett worked as Chief Accounting Officer at Climb Bio, Inc. from 2023 to 2025.
Ms. Pimblett completed undergraduate and graduate degrees at the University of Washington.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CLIMB BIO, INC. 0,03 % | 20/06/2025 | 18 888 ( 0,03 % ) | 259 332 $ | 31/08/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
DomainTools LLC
DomainTools LLC Packaged SoftwareTechnology Services Develops threat intelligence and domain security platform for enterprises and governments | Comptroller/Controller/Auditor | 01/03/2021 |
Avvo, Inc.
Avvo, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an online legal directory | Comptroller/Controller/Auditor | 01/03/2019 |
| CLIMB BIO, INC. | Comptroller/Controller/Auditor | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avvo, Inc.
Avvo, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an online legal directory | Commercial Services |
DomainTools LLC
DomainTools LLC Packaged SoftwareTechnology Services Develops threat intelligence and domain security platform for enterprises and governments | Technology Services |
Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national